Evotec SE EVO
NASDAQ EVO
$1.60 -0.04 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evotec SE (EVO) Return on Sales [ROS] (2009 - 2025)

Updated

Evotec SE's Return on Sales [ROS] was 14.92% in the quarter ended Dec 31, 2025, up 12.39 percentage points from 2.53% a year earlier and up 42.08 percentage points from the prior quarter.

Analysis

Evotec SE (EVO) Return on Sales [ROS] (2009 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Return on Sales [ROS] at Evotec SE came in at -0.01%, up 17.87 percentage points from the prior year.

  • Return on Sales [ROS] shows a five-year change of -9.70 percentage points (years ended Dec 2020 to Dec 2025).
  • In earlier years, Return on Sales [ROS] was -17.88% in the year ended Dec 31, 2024 (-11.80 pp), -6.08% in the year ended Dec 31, 2023 (-8.85 pp), 2.77% in the year ended Dec 31, 2022 (-3.86 pp) and 6.63% in the year ended Dec 31, 2021 (-3.06 pp).
  • The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Return on Sales [ROS] since the quarter ended Mar 31, 2022.
  • Compared with a year earlier, Return on Sales [ROS] was higher in two of the last seven quarters, with an average year-over-year change of -3.54 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was the quarter ended Jun 30, 2025 (a gain of 38.87 percentage points); the worst was the quarter ended Sep 30, 2022 (a drop of 11102.01 percentage points).
  • Per Business Quant data, EVO's Return on Sales [ROS] in the three quarters before the quarter ended Dec 31, 2025 was -27.15% (quarter ended Sep 30, 2025), -16.22% (quarter ended Jun 30, 2025) and -10.01% (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Iqvia Holdings 42.51 Bn 34.35 Bn 1.44 Bn 11.58%
2 Medpace Holdings 16.73 Bn 14.79 Bn 201.64 Mn 20.76%
3 Charles River Laboratories International 13.84 Bn 13.08 Bn 363.37 Mn 11.94%
4 Icon 12.41 Bn 9.52 Bn 479.29 Mn 6.68%
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn 2.18%
6 Ginkgo Bioworks Holdings 786.20 Mn 24.11 Mn 18.44 Mn -290.47%
7 Evotec SE 568.89 Mn -1.00 Bn - -
8 Champions Oncology 68.76 Mn 44.41 Mn 7.70 Mn -2.69%
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn -159.86%
10 Natural Alternatives International 8.92 Mn -19.16 Mn 1.73 Mn -38.18%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14.92%
Sep 30, 2025 -27.15%
Jun 30, 2025 -16.22%
Mar 31, 2025 -10.01%
Dec 31, 2024 2.53%
Sep 30, 2024 -14.33%
Jun 30, 2024 -55.09%
Mar 31, 2024 -8.72%
Dec 31, 2023 5.86%
Sep 30, 2023 6.21%
Jun 30, 2023 -16.99%
Dec 31, 2022 1.67%
Sep 30, 2022 7.78%
Jun 30, 2022 -2.19%
Mar 31, 2022 281.16%
Dec 31, 2021 6.63%
Sep 30, 2021 11,109.79%
Jun 30, 2021 1.11%
Mar 31, 2021 5,092.99%
Dec 31, 2020 9.69%
API Access

Evotec SE Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVO&period=max&api_key=YOUR_API_KEY